Also, the IBD-related proinflammatory cytokines, such as IL-1β, IL-6 and TNF-α (35), were markedly reduced in DSS-treated PAD4-/- colon tissue, as compared to the controls (Figure 6D). This evidence concerns the gene IL1B and inflammatory bowel disease.